Polyautoimmunity Diagnosis and Significance

Size: px
Start display at page:

Download "Polyautoimmunity Diagnosis and Significance"

Transcription

1 Polyautoimmunity Diagnosis and Significance Juan-Manuel Anaya, MD, PhD Center for Autoimmune Diseases Research Universidad del Rosario Bogota, Colombia

2 Polyautoimmunity Polyautoimmunity: Autoimmune diseases (ADs) co-occurring within patients. Multiple Autoimmune Syndrome : 3 or more ADs in the same patient. Other terms: associated, overlap syndrome coexistent secondary

3 Multiple Autoimmune Syndromes Three or more well defined autoimmune diseases in a single patient Humbert P, Dupond JL. Ann Med Interne Paris 1988;139:

4 Polyautoimmunity Polyautoimmunity in RA, SS, SLE, and other autoimmune diseases. Factors influencing polyautoimmunity Does polyautoimmunity influence the severity of autoimmune diseases?

5 Polyautoimmunity in Rheumatoid Arthritis 130/ 955 (13.6%) patients disclosed polyautoimmunity. 161 additional ADs were observed. AITD 76 (8%) SS 50 (5.2%) SLE 24 (2.5%) MAS 23 (2.4%) Factors influencing polyautoimmunity in RA : Familial autoimmunity, Familial RA, and toxics. Multiple autoimmune syndrome was associated with extra-articular manifestations. Anaya JM, et al. EULAR 2015 THU0152

6 Familial Autoimmunity and Polyautoimmunity in RA When familial autoimmunity was present, the risk of developing polyautoimmunity was similar in men and women, whereas the risk of polyautoimmunity without FAI was higher in women than in men. Anaya JM, et al. EULAR 2015 THU0152

7 Familial RA and Polyautoimmunity Anaya JM, et al. EULAR 2015 THU0152

8 Toxics and Polyautoimmunity in RA Anaya JM, et al. EULAR 2015 THU0152

9 Multiple Autoimmune Syndrome and extra-articular manifestations in RA RA RA + 1 Autoimmune Disease MAS Anaya JM, et al. EULAR 2015 THU0152

10 Characteristics of patients with Rhupus (as compared with SLE patients) Older (46.42 ± vs ± yrs, p <0.001) Later age at onset of the disease (35.9 ± vs ± yrs, p=0.017). Similar duration of the disease (9 ± 7.5 vs. 7.5 ± 7.3 years, p=0.3). The mean age at onset of RA was 30 ± yrs. RA preceded SLE in 15 patients (62.5%). The PPV and NPV of anti-ccp3 for rhupus were 0.62 and 0.91 respectively. Rhupus (SLE&RA) Amaya-Amaya J, et al. Lupus Feb 9.

11 Polyautoimmunity in Systemic Lupus Erythematosus 40% 35% 30% 25% 20% 15% 10% 5% 0% APS SS AITD Rojas-Villarraga A, et al. Autoimmun Rev. 2010;9: Franco J, et al. Clin Endocrinol (Oxf) Nov 8. Franco JS, et al. PLoS One. 2014;9:e

12 Factors Influencing Polyautoimmunity in Systemic Lupus Erythematosus Variable AOR 95% CI p Gender (female) Articular involvement Familial autoimmunity Anti-Ro Ab Origin (Colombia vs Spain) < Rojas-Villarraga A, et al. Autoimmun Rev. 2010;9:

13 Does ancestry influence polyautoimmunity?

14 Influence of Ancestry on Polyautoimmunity Population: 508 individuals: 240 single autoimmune disease, 51 with polyautoimmunity, 36 with MAS, and 181 matchedcontrols. Marshfield Screening Set STRs, 32 AIMs. The individual Admixture map was built using STRUCTURE The number of cluster was set in 3, the number of burn-in simulations was set in 5000 and simulations for inference. A MANOVA model on arl transformed ancestral profiles was adjusted to evaluate differences in ancestral profiles among different cases (AD, POLY and MAS) and controls. Molano-González N et al. Submitted

15 Ameridian Ancestry Influences Polyautoimmunity Reference populations and Colombian population. Colombian population by autoimmune disease status. Molano-González N et al. Submitted

16 Ameridian Ancestry Influences Polyautoimmunity p: p: Amerindian ancestry European ancestry Molano-González N et al. Submitted

17 Autoimmune Thyroid Disease in Systemic Lupus Erythematosus Franco J, et al. Clin Endocrinol (Oxf) Nov 8.

18 Autoimmune Thyroid Disease in Systemic Lupus Erythematosus Sjögren's syndrome and smoking are predictive factors associated with the development of AITD in SLE Franco J, et al. Clin Endocrinol (Oxf) Nov 8.

19 Polyautoimmunity in Sjögren's Syndrome Autoimmune Diseases Prevalence N = 410 (%) SS alone 275 (67) SS + AD (Polyautoimmunity) 135 (33) SS + 1 AD 101 (24.6) SS + 2 or more ADs (MAS) 35 (8.5) Amador-Patarroyo MJ, et al. J Autoimmun. 2012;39:

20 Polyautoimmunity in Sjögren's Syndrome N=410 Characteristic SS alone N=276 SS PA N=134 Disease duration 4 (6) 7.86 (7) Age at diagnosis 46.7 ± ± Age at onset 45.4 ± ± p Amador-Patarroyo MJ, et al. J Autoimmun. 2012;39:

21 Prevalence % Polyautoimmunity in Sjögren's Syndrome , ,3 7, ,6 1,4 1,1 0,7 0,3 0,4 0,4 0,4 0,4 AITD RA SLE APS SSc VAS IBD MS VIT AIH PSO PeA Autoimmune Disease Amador-Patarroyo MJ, et al. J Autoimmun. 2012;39:

22 Prevalence Polyautoimmunity in Sjögren's Syndrome MAS cases SS-AITD-SLE SS-AITD-RA SS-SLE-APS SS-SLE-RA MAS phenotypes Amador-Patarroyo MJ, et al. J Autoimmun. 2012;39:

23 Polyautoimmunity in Sjögren's Syndrome Characteristic SS Alone % SS-PA % AOR 95% CI p Positive smoking status Spontaneous abortions ANAs (+) Amador-Patarroyo MJ, et al. J Autoimmun. 2012;39:

24 Polyautoimmunity in SSc, PBC, Vitiligo, AITD and MS Systemic Sclerosis. 38% Hudson M, et al. J Autoimmun 2008;31: Elhai M, et al. Autoimmun Rev. 2013;12: Primary Biliary Cirrhosis. 32% Gershwin ME, et al. Hepatology 2005;42: Vitiligo. 27% Amerio P, et al. Eur J Dermatol. 2010;20: Myastenia Gravis. 13% Mao ZF, et al. Int J Neurosci 2011;121: Autoimmune Thyroid Diseases. 14% Boelaert K, et al. Am J Med 2010;123:183.e1-9. Multiple Sclerosis. 8% Deretzi G, et al. Acta Neurol Scand. 2015;131: Marrie RA, et al. Mult Scler. 2015;21:

25 Clustering of autoimmune diseases is not random Anaya et al. Clin Rev Allergy Immunol. 2012;43:

26 Polyautoimmunity Polyautoimmunity in SS, SLE, and other autoimmune diseases Multiple Autoimmune Syndrome Factors influencing polyautoimmunity Does polyautoimmunity influence the severity of autoimmune diseases?

27 Polyautoimmunity and Severity Some reports favor severity More erosive disease in Rhupus and anti-ccp antibodies Higher Incidence of malignancy in RA and SS Low rates of remission in MG and AITD More severe disease in T1D and celiac disease Vasculitis is associated with high SLEDAI score in SLE More severity of SLE+APS. Christensen et al. Acta Neurol Scand 1995;91: Valerio et al. Diabetologia 2002;45: Ramos-Casals et al. Medicine (Baltimore). 2006;85: Chan et al. J Rheumatol Jan;35: Kauppi et al. Cancer Causes Control 1997;8: Franco JS, et al. PLoS One. 2014;9:e

28 Polyautoimmunity and Severity Some reports indicate less severity Milder disease in MG and AITD Milder disease in SSc and AITD SS or AITD do not influence outcome in SLE (nephritis) Marinó et al. J Clin Endocrinol Metab 1997;82: Avouac et al. J Rheumatol 2010;37: Rojas-Villarraga et al. Lupus : 150 Franco et al. EULAR 2014

29 Polyautoimmunity Conclusions Polyautoimmunity is a frequent condition (10-40%). Factors associated with polyautoimmunity include gender (female), familial autoimmunity, tobacco smoking, ancestry (amerindian). Based on polyautoimmunity and depending on severity, autoimmune diseases may be categorized as major and minor conditions. In this sense, how polyautoimmunity affects major autoimmune diseases warrants further investigation.

30 Polyautoimmunity Conclusions The assessment and clustering of polyautoimmunity will help to define plausible approaches to studying the common mechanisms of these diseases (i.e., the autoimmune tautology). Identification of commonalities among autoimmune diseases may provide insights about salient mechanisms that are necessary and perhaps sufficient for autoimmunity to occur. Polyautoimmunity, as an extreme phenotype of autoimmunity, would be critical for dissecting genes of major effect conferring susceptibility to autoimmunity.

31 Rhetoric ταυτολογία From Greek tauto, the same ; logos, word/idea. Tautology is an obvious statement. Logic Tautology is a formula, which is true in every possible interpretation. Vpq = AD1 ~ AD2 ~ AD3 Anaya JM. Arthritis Res Ther. 2010;12:147. Anaya JM. Autoimmun Rev. 2012;11: Anaya et al. Clin Rev Allergy Immunol. 2012;43: Anaya et al. Autoimmune Dis. 2012;2012:

32 The Autoimmune Tautology Common mechanisms of autoimmune diseases Female predominance Shared subphenotypes Polyautoimmunity Familial aggregation Age at onset Similar pathophysiology Autoimmune ecology Ancestry and genetic factors Treatment

33 Shared Subphenotypes Among Autoimmune Diseases Clinical Non-erosive arthritis Photosensitivity Raynaud s phenomenon Alopecia Depression Cardiovascular disease Laboratory Antinuclear antibodies Rheumatoid factor Anti-Ro antibodies

34 Imbalance of Regulatory Cells in Autoimmune Diseases Luu VP et al. Autoimmunity 2014;47:1-12. Vadasz Z et al FEBS Lett. 2013;587: Yang M, Cell Mol Immunol 2013;10: Berthelot JM, et al. Joint Bone Spine 2013;80:18-22.

35 Th17 Cells in Inflammation and Autoimmunity Singh RP, et al Autoimmun Rev. 2014

36 Type 1 interferon is a central factor in Autoimmunity Presence of IFN signature in autoimmune diseases. Regulation of MHC expression. Increased amounts of IFN α. Activates the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, leading to transcription of IFN-stimulated genes (ISGs). Ivashkiv LB, Donlin LT. Nat Rev Immunol 2014;14: Wahren-Herlenius M, Dörner T. Lancet 2013;382:

37 Epstein Barr virus and Autoimmune Diseases IgG anti-ebv Anaya et al. Autoimmunity. From bench to bedside. 2013

38 Smoking is a risk factor for autoimmune diseases and their severity Primary Biliary Cirrhosis Rheumatoid Arthritis Systemic Lupus Erythematosus Autoimmune Thyroid Disease Multiple Sclerosis Brix TH, et al. Arch Intern Med. 2000;160: Belbasis L, et al. Lancet Neurol. 2015;14: Juran BD, et al. Semin Liver Dis. 2014;34: Costenbader KH, Karlson EW. Lupus 2006;15: Di Giuseppe D, et al. Arthritis Res Ther. 2013;15:R56.

39 The genetic factors for autoimmune diseases consist of 2 forms: those common to many diseases and those specific for a given disorder.

40 The Autoimmune Tautology Common mechanisms of autoimmune diseases Female predominance Shared subphenotypes Polyautoimmunity Familial aggregation Age at onset Similar pathophysiology Autoimmune ecology Ancestry and genetic factors Similar treatment

41 Polyautoimmunity Conclusions Identification of commonalities among ADs may provide insights about salient mechanisms that are necessary and perhaps sufficient for autoimmunity to occur. Polyautoimmunity, as an extreme phenotype of autoimmunity, would be critical for dissecting genes of major effect conferring susceptibility to autoimmunity.

42 Polyautoimmunity Genes HLA-DRB1, HLA-DQB1, CD226, PTPN22, STAT4, GPR103, TNFAIP3, LRP1/STAT6

43 Acknowledgments

44 Thank you!

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval 135091662 Age 45 Years Gender Male 29/8/2017 120000AM 29/8/2017 100215AM 29/8/2017 110825AM Ref By Final RHEUMATOID AUTOIMMUNE COMREHENSIVE ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), SERUM ----- 20-60

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091593 Age 25 Years Gender Male 30/8/2017 91600AM 30/8/2017 93946AM 31/8/2017 84826AM Ref By Final COLLAGEN DISEASES ANTIBODY ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF),

More information

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD Undifferentiated Connective Tissue Disease and Overlap Syndromes Mark S. Box, MD Overlap Syndromes As many as 25% of patients with rheumatic diseases with systemic symptoms cannot be definitely diagnosed

More information

Autoimmune diagnostics. A comprehensive product line for the detection of autoantibodies

Autoimmune diagnostics. A comprehensive product line for the detection of autoantibodies Autoimmune diagnostics A comprehensive product line for the detection of autoantibodies Autoimmune diagnostics Autoimmune diseases are chronic inflammatory processes with an indeterminate etiology. They

More information

Review Article Introducing Polyautoimmunity: Secondary Autoimmune Diseases No Longer Exist

Review Article Introducing Polyautoimmunity: Secondary Autoimmune Diseases No Longer Exist Autoimmune Diseases Volume 2012, Article ID 254319, 9 pages doi:10.1155/2012/254319 Review Article Introducing Polyautoimmunity: Secondary Autoimmune Diseases No Longer Exist Adriana Rojas-Villarraga,

More information

New Therapeutic Perspectives in Sjögren's Syndrome

New Therapeutic Perspectives in Sjögren's Syndrome New Therapeutic Perspectives in Sjögren's Syndrome Claudio Vitali Chairman of the EULAR Task Force for Disease Activity Criteria in Sjögren s Syndrome. Member of the Steering Committee for the ACR- EULAR

More information

Review Article Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis

Review Article Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis Autoimmune Diseases Volume 2012, Article ID 569728, 10 pages doi:10.1155/2012/569728 Review Article Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis Paola Cruz-Tapias, 1,

More information

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904)

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) Rheumatoid Arthritis Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) 503-6999. 1 Disclosures Speaker Bureau: Abbvie 2 Objectives Better understand the pathophysiology

More information

Key words: antiphospholipid syndrome, trombosis, pathogenesis

Key words: antiphospholipid syndrome, trombosis, pathogenesis 26. XI,. 4/2011,.,..,..,., -..,,. 2GPI. -,.,,., -,, -, -,,,,, IL-1, IL-2, IL-6, IL-8, IL-12, IL-10, TNF, INF-. :,, N. Stoilov, R. Rashkov and R. Stoilov. ANTIPHOSPHOLIPID SYNDROME HISTORICAL DATA, ETI-

More information

What is Autoimmunity?

What is Autoimmunity? Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.

More information

What is Autoimmunity?

What is Autoimmunity? Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.

More information

Detection of Anti-nuclear Antibodies in Women with Hyperprolactinaemia

Detection of Anti-nuclear Antibodies in Women with Hyperprolactinaemia Detection of Anti-nuclear Antibodies in Women with Hyperprolactinaemia Salahdeen Ismail Mohammed 12, Alaaeldeen Balal Ahmed 1, Nuha Abdurhaman 2, Abdalla Hassan Sharief 2 1 Faculty of Medical Laboratory

More information

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation Marcelo C. Pasquini, MD, MSc HVD05_1.ppt Outline Review of autoimmune diseases (AID). Role of transplantation for AID Data collection:

More information

What will we discuss today?

What will we discuss today? Autoimmune diseases What will we discuss today? Introduction to autoimmune diseases Some examples Introduction to autoimmune diseases Chronic Sometimes relapsing Progressive damage Epitope spreading more

More information

ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman.

ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman. ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman. to change at any time www.arlar.org info@arlar.org #ArLAR2018 Thursday, 22

More information

A retrospective study of long-term outcomes in 152 patients with primary Sjögren s syndrome: 25-year experience

A retrospective study of long-term outcomes in 152 patients with primary Sjögren s syndrome: 25-year experience Clinical Medicine 2014 Vol 14, No 2: 157 64 ORIGINAL REVIEW A retrospective study of long-term outcomes in 152 patients with primary Sjögren s syndrome: 25-year experience Authors: Esha Abrol, A Cristina

More information

Mechanisms of Autontibodies

Mechanisms of Autontibodies Mechanisms of Autontibodies Production in Rheumatic Diseases Eisa Salehi PhD Tehran University of Medical Sciences Immunology Department Introduction Rheumatic diseases: Cause inflammation, swelling, and

More information

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18 Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Thyroid Peroxidase (TPO) Antibody 5.0 IU/mL [0.0-9.0] 18-289-900139 16-Oct-18 Complement Component 3 50 mg/dl 18-289-900139

More information

The autoimmune burden in juvenile idiopathic arthritis

The autoimmune burden in juvenile idiopathic arthritis Tronconi et al. Italian Journal of Pediatrics (2017) 43:56 DOI 10.1186/s13052-017-0373-9 RESEARCH Open Access The autoimmune burden in juvenile idiopathic arthritis Elena Tronconi 1,2*, Angela Miniaci

More information

ACP-BSG meeting The liver in systemic inflammatory disorders. Dr Adrian C Bateman Southampton University Hospitals NHS Trust

ACP-BSG meeting The liver in systemic inflammatory disorders. Dr Adrian C Bateman Southampton University Hospitals NHS Trust ACP-BSG meeting 10.12.09 The liver in systemic inflammatory disorders Dr Adrian C Bateman Southampton University Hospitals NHS Trust Wide range of diseases General inflammatory disorders Connective tissue

More information

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity PLENARY S BREAKS NETWORKING EVENTS PARALLEL S INDUSTRY SUPPORTED S E-POSTERS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 Coffee Break 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30

More information

Value-added reporting. X. Bossuyt

Value-added reporting. X. Bossuyt Value-added reporting X. Bossuyt COMMUNICATING DIAGNOSTIC ACCURACY Communicating diagnostic accuracy Question 1 Sensitivity: 95% Specificity: 9% Pre-test probability: 2.5% Post-test probability??? 1% 2%

More information

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity PLENARY S BREAKS NETWORKING EVENTS PARALLEL S INDUSTRY SUPPORTED S E-POSTERS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 Coffee Break 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30

More information

BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM

BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM PLENARY SESSIONS BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 COFFEE BREAK 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30

More information

Staging of Type 1 Diabetes: Clinical Implications. April Deborah Hefty, MN, RN, CDE.

Staging of Type 1 Diabetes: Clinical Implications. April Deborah Hefty, MN, RN, CDE. Staging of Type 1 Diabetes: TT Clinical Implications April 2016 Deborah Hefty, MN, RN, CDE dhefty@benaroyaresearch.org BRI s major contributions to type 1 diabetes research Identified type 1 diabetes susceptibility

More information

The Genetic Epidemiology of Rheumatoid Arthritis. Lindsey A. Criswell AURA meeting, 2016

The Genetic Epidemiology of Rheumatoid Arthritis. Lindsey A. Criswell AURA meeting, 2016 The Genetic Epidemiology of Rheumatoid Arthritis Lindsey A. Criswell AURA meeting, 2016 Overview Recent successes in gene identification genome wide association studies (GWAS) clues to etiologic pathways

More information

Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.

Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine. Development of SLE among Patients Seen in Consultation: Long-Term Follow-Up Abstract # 1699 May Al Daabil, MD Bonnie L. Bermas, MD Alexander Fine Hsun Tsao Patricia Ho Joseph F. Merola, MD Peter H. Schur,

More information

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.

More information

Contents. Welcome to EULAR 2012 Berlin... iii AbstractsReviewers... iv. Speakers Abstracts

Contents. Welcome to EULAR 2012 Berlin... iii AbstractsReviewers... iv. Speakers Abstracts vii Welcome to EULAR 2012 Berlin... iii AbstractsReviewers... iv Speaker Presentations Speakers Abstracts Wednesday, 6 June 2012 SP0001 Pre-conference outlook... 2 SP0002 WIN Session 1... 2 SP0003 SP0005

More information

Clinical Laboratory. [None

Clinical Laboratory. [None Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Double-Stranded DNA (dsdna) Ab IgG ELISA Detected * [None 18-289-900151 Detected] Double-Stranded DNA (dsdna) Ab IgG

More information

PATHOGENESIS OF RHEUMATOID ARTHRITIS

PATHOGENESIS OF RHEUMATOID ARTHRITIS PATHOGENESIS OF RHEUMATOID ARTHRITIS Division of Rheumatology Department of Internal Medicine College of Medicine Seoul National University Seoul National University Bundang Hospital Yun Jong Lee Rheumatoid

More information

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18 Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Rheumatoid Factor

More information

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc. Diseases of Immunity 2017 CL Davis General Pathology Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc. Autoimmunity Reflects a loss of immunologic tolerance Mechanisms Auto-antibodies

More information

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Is it Autoimmune or NOT! Presented to AONP! October 2015! Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells

More information

J. Lee Nelson, MD Fred Hutchinson Cancer Research Ctr & University of Washington, Seattle, Washington, USA

J. Lee Nelson, MD Fred Hutchinson Cancer Research Ctr & University of Washington, Seattle, Washington, USA MICROCHIMERISM IN SPACE AND OVER TIME (OUR INTERSTELLAR MOVIE) J. Lee Nelson, MD Fred Hutchinson Cancer Research Ctr & University of Washington, Seattle, Washington, USA Microchimerism (Mc): a small number

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval 135091660 Age 44 Years Gender Male 29/8/2017 120000AM 29/8/2017 100219AM 29/8/2017 105510AM Ref By Final EXTRACTABLENUCLEAR ANTIGENS (ENA), QUANTITATIVE ROFILE CENTROMERE ANTIBODY, SERUM 20-30 Weak ositive

More information

Bachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES

Bachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES Bachelor of Chinese Medicine (2002 2003) BCM II Dr. EYT Chan February 6, 2003 9:30 am 1:00 pm Rm 134 UPB AUTOIMMUNE DISEASES 1. Introduction Diseases may be the consequence of an aberrant immune response,

More information

CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease

CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease Maria Isabel Fiel, M.D. The Mount Sinai Medical Center New York, New York Case A 57 yo man, 7 months

More information

Immune tolerance, autoimmune diseases

Immune tolerance, autoimmune diseases Immune tolerance, autoimmune diseases Immune tolerance Central: negative selection during thymic education deletion of autoreactive B-lymphocytes in bone marrow Positive selection in the thymus Negative

More information

Autoantibodies panel ANA

Autoantibodies panel ANA Autoantibodies panel ANA Anti-nuclear antibodies, ANA screening General: Anti-nuclear antibodies (ANA) contain all kinds of autoantibodies against nuclear antigens. Their targets are cell components in

More information

Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW POLAND prof. Małgorzata Wisłowska

Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW POLAND prof. Małgorzata Wisłowska Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW 02-507 POLAND prof. Małgorzata Wisłowska MD, PhD 1 Klinika Chorób Wewnętrznych i Reumatologii

More information

UPDATES ON PEDIATRIC SLE

UPDATES ON PEDIATRIC SLE UPDATES ON PEDIATRIC SLE BY ANGELA MIGOWA, PEDIATRIC RHEUMATOLOGIST/SENIOR INSTRUCTOR AKUHN MBCHB-UON, MMED-AKUHN,PEDIATRIC RHEUMATOLOGY- MCGILL UNIVERSITY HEALTH CENTRE ROSA PARKS OBJECTIVES RECOGNIZE

More information

Insights into the DX of Pediatric SLE

Insights into the DX of Pediatric SLE Insights into the DX of Pediatric SLE Dr. John H. Yost Pediatric Rheumatology Children s Hospital at Dartmouth Assistant Professor of Medicine Geisel School of Medicine at Dartmouth john.h.yost@hitchcock.org

More information

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings Case # 2 Christopher Larsen, MD Arkana Laboratories Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content

More information

Undifferentiated connective tissue diseases in 2004

Undifferentiated connective tissue diseases in 2004 Undifferentiated connective tissue diseases in 2004 M. Mosca, C. Baldini, S. Bombardieri Rheumatology Unit, Department of Internal Medicine, University of Pisa, Pisa, Italy Please address correspondence

More information

The Role of Plasmacytoid Dendritic Cells in Psoriasis

The Role of Plasmacytoid Dendritic Cells in Psoriasis 6 ème Journée du Groupe de Recherche sur le Psoriasis Paris, 9 novembre 2012 The Role of Plasmacytoid Dendritic Cells in Psoriasis Dr Curdin Conrad, PD & MER Department of Dermatology Psoriasis: Clinical

More information

Understanding Autoimmune Diseases: Evolving Issues. Alvina D. Chu, M.D. April 23, 2009

Understanding Autoimmune Diseases: Evolving Issues. Alvina D. Chu, M.D. April 23, 2009 Understanding Autoimmune Diseases: Evolving Issues Alvina D. Chu, M.D. April 23, 2009 Objectives Define the key pathogenic characteristics of: Type I diabetes mellitus Multiple sclerosis Rheumatoid arthritis

More information

Recurrent Arthritis and Anti-cyclic Citrullinated Peptide Positivity during Interferon-beta 1a Treatment in Two Patients with Multiple Sclerosis

Recurrent Arthritis and Anti-cyclic Citrullinated Peptide Positivity during Interferon-beta 1a Treatment in Two Patients with Multiple Sclerosis Case Reports in Clinical Practice VOL 1, NO 2, Spring 2016 Case Report http://crcp.tums.ac.ir Recurrent Arthritis and Anti-cyclic Citrullinated Peptide Positivity during Interferon-beta 1a Treatment in

More information

Association of anti-mcv autoantibodies with SLE (Systemic Lupus Erythematosus) overlapping with various syndromes

Association of anti-mcv autoantibodies with SLE (Systemic Lupus Erythematosus) overlapping with various syndromes International Journal of Medicine and Medical Sciences Vol. () pp. 21-214, June 211 Available online http://www.academicjournals.org/ijmms ISSN 2-972 211 Academic Journals Full Length Research Paper Association

More information

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells

More information

Hangzhou, 15 March Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam

Hangzhou, 15 March Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam Clinical Aspects of Primary Biliary Cirrhosis Hangzhou, 15 March 2008 Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam Epidemiology of Primary

More information

Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic

Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic SLIDE 3: Introduction to autoimmune diseases Chronic Autoimmune diseases Sometimes relapsing : and remitting. which means that they present as attacks Progressive damage Epitope spreading more and more

More information

Regulatory B cells in autoimmunity. Liwei Lu University of Hong Kong, China

Regulatory B cells in autoimmunity. Liwei Lu University of Hong Kong, China Regulatory B cells in autoimmunity Liwei Lu University of Hong Kong, China Multiple functions of B cells in immunity LeBien and Tedder, Blood (2008) B cell functions in autoimmune pathogenesis The Immunopathogensis

More information

AUTOIMMUNITY CLINICAL CORRELATES

AUTOIMMUNITY CLINICAL CORRELATES AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel

More information

AUTOIMMUNITY TOLERANCE TO SELF

AUTOIMMUNITY TOLERANCE TO SELF AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel

More information

Assays. New. New. Combinations. Possibilities. Patents: EP , AU

Assays. New. New. Combinations. Possibilities. Patents: EP , AU Assays Patents: EP 2362222, AU 2011217190 New Combinations New Possibilities Technology Classical Handling of Autoimmune Diagnostics 2-Step Diagnostics 1 st Screening 2 nd Confirmation Cell based IFA ELISA

More information

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital Outline What is ANA? How to detect ANA? Clinical application Common autoantibody in ANA diseases Outline What is ANA? How to detect ANA? Clinical

More information

AMPLIADO SÍNDROME ANTIFOSFOLÍPIDO SÍNDROME DE SJÖGREN María José Cuadrado Lozano Clínica Universidad de Navarra-Madrid

AMPLIADO SÍNDROME ANTIFOSFOLÍPIDO SÍNDROME DE SJÖGREN María José Cuadrado Lozano Clínica Universidad de Navarra-Madrid AMPLIADO SÍNDROME ANTIFOSFOLÍPIDO SÍNDROME DE SJÖGREN María José Cuadrado Lozano Clínica Universidad de Navarra-Madrid PLASMABLAST PROLIFERATION IS ASSOCIATED WITH TLR7 POLYMORPHISMS AND UPREGULATION OF

More information

Editing file. Color code: Important in red Extra in blue. Autoimmune Diseases

Editing file. Color code: Important in red Extra in blue. Autoimmune Diseases Editing file Color code: Important in red Extra in blue Autoimmune Diseases Objectives To know that the inflammatory processes in autoimmune diseases are mediated by hypersensitivity reactions (type II,

More information

Paradoxial Safety Signals from Biologics

Paradoxial Safety Signals from Biologics Paradoxial Safety Signals from Biologics Christopher Ritchlin, MD, MPH Professor of Medicine Director, Translational Immunology Research Center University of Rochester Medical Center Rochester, NY Disclosures

More information

Supplementary Figure Legends

Supplementary Figure Legends Supplementary Figure Legends Supplementary Figure 1. Comparison of RNP IC-mediated NET formation. Quantification of DNA release induced by ICs consisting of SmRNP combined with SLE IgG 961 (n = 10), 1032

More information

Patient and Partner Consult Report

Patient and Partner Consult Report Patient and Partner Consult Report Clinical History History of primary infertility for a period of about 2 years o Including 6 failed IUI cycles and 3 failed IVF cycles Low success rate of embryos surviving

More information

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly

More information

Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies

Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies Directions: Each of the numbered items or incomplete statements in this section is followed by answers or by completions of the statement.

More information

Research Article Cardiovascular Disease in Latin American Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study and a Systematic Review

Research Article Cardiovascular Disease in Latin American Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study and a Systematic Review Autoimmune Diseases Volume 2013, Article ID 794383, 20pages http://dx.doi.org/10.1155/2013/794383 Research Article Cardiovascular Disease in Latin American Patients with Systemic Lupus Erythematosus: A

More information

Contents. Welcome Address... iii EULAR 2017 Abstracts Reviewers... iv. Speakers Abstracts

Contents. Welcome Address... iii EULAR 2017 Abstracts Reviewers... iv. Speakers Abstracts vi Welcome Address... iii EULAR 2017 Abstracts Reviewers... iv Speaker Presentations Speakers Abstracts Wednesday, 14 June 2017 SP0001 SP0004 Joint EULAR - APLAR session: novel animal models - where no

More information

LUPUS. and Associated Conditions LUPUSUK 2018

LUPUS. and Associated Conditions LUPUSUK 2018 11 LUPUS and Associated Conditions LUPUSUK 2018 LUPUS and Associated Conditions Lupus most often occurs alone. However, in many people, other medical conditions caused by or associated with lupus can occur.

More information

Comparison of Performance of ELISA with Indirect Immunofluoresence for the Testing of Antinuclear Antibodies

Comparison of Performance of ELISA with Indirect Immunofluoresence for the Testing of Antinuclear Antibodies International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 12 (2016) pp. 423-427 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.512.046

More information

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP Autoimmune hepatobiliary diseases The liver is an important target for immunemediated injury. Three disease phenotypes are recognized:

More information

Cigarette Smoking is not a Risk Factor for Systemic Sclerosis

Cigarette Smoking is not a Risk Factor for Systemic Sclerosis Brief Report Arthritis & Rheumatism DOI 10.1002/art.30492 Cigarette Smoking is not a Risk Factor for Systemic Sclerosis Authors: Prateek Chaudhary 1, Xing Chen 2, Shervin Assassi 1, Olga Gorlova 2, Hilda

More information

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease Disclosures Clinical Approach: Evaluating CTD-ILD for the pulmonologist Industry relationships: Actelion, atyr Pharma, Boehringer-Ingelheim, Genentech- Roche, Gilead Aryeh Fischer, MD Associate Professor

More information

Correlation Between Autoimmune Thyroid Disease, Rheumatoid Factor And Vitiligo in Hypothyroid Patients In Ranchi, Jharkhand.

Correlation Between Autoimmune Thyroid Disease, Rheumatoid Factor And Vitiligo in Hypothyroid Patients In Ranchi, Jharkhand. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 8 Ver. VII (Aug. 2017), PP 35-39 www.iosrjournals.org Correlation Between Autoimmune Thyroid

More information

CIC Edizioni Internazionali. Sarcoidosis and autoimmune disorders. A case report and review of the literature. Mini-review. in women in the seventh

CIC Edizioni Internazionali. Sarcoidosis and autoimmune disorders. A case report and review of the literature. Mini-review. in women in the seventh Mini-review Sarcoidosis and autoimmune disorders. A case report and review of the literature Varan Ozkan¹ Kokturk Nurdan² ¹ Gazi University Faculty of Medicine, Department of Internal Medicine, Division

More information

Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study

Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study Adv Ther (2017) 34:2481 2490 DOI 10.1007/s12325-017-0627-3 ORIGINAL RESEARCH Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study Teresa A. Simon. Hugh Kawabata.

More information

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 Jeopardy Antibodies & more antibodies Aching joints What s the rash? Potpourri Image Challenge $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500

More information

Autoimmune diseases, their pathogenic mechanisms and treatment of unwanted immune responses (Janeway s Immunobiology)

Autoimmune diseases, their pathogenic mechanisms and treatment of unwanted immune responses (Janeway s Immunobiology) Autoimmune diseases, their pathogenic mechanisms and treatment of unwanted immune responses (Janeway s Immunobiology) Picture source: https://www.klini kum.uniheidelberg.de/fil eadmin/pressest elle/pm_neu/20

More information

different serological and histological manifestations and a high incidence of D-penicillamine side effects. Materials

different serological and histological manifestations and a high incidence of D-penicillamine side effects. Materials Annals of the Rheu)natic Diseases, 1985, 44, 215-219 Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects HARALAMPOS

More information

MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism

MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism SCHMAIEL SHIRDEL CONTENT 2 Introduction Autoimmune diseases Classification Involved components Autoimmune

More information

Season Dependent Changes in the Expression of Protein Kinase C Isoenzymes in a Female Patient with Systemic Lupus Erythematosus

Season Dependent Changes in the Expression of Protein Kinase C Isoenzymes in a Female Patient with Systemic Lupus Erythematosus Pathology & Oncology Research https://doi.org/10.1007/s12253-019-00591-7 SHORT COMMUNICATION Season Dependent Changes in the Expression of Protein Kinase C Isoenzymes in a Female Patient with Systemic

More information

MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt.

MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt. MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt. AUTOIMMUNE DISEASE RA SLE VASCULITIS RELAPSING POLYCHONDRITIS SS DM/PM SJOGREN S SYNDROME RHEUMATOID ARTHRITIS Classically immune mediated

More information

. Autoimmune disease. Dr. Baha,Hamdi.AL-Amiedi Ph.D.Microbiology

. Autoimmune disease. Dr. Baha,Hamdi.AL-Amiedi Ph.D.Microbiology . Autoimmune disease Dr. Baha,Hamdi.AL-Amiedi Ph.D.Microbiology, Paul Ehrich The term coined by the German immunologist paul Ehrich ( 1854-1915) To describe the bodys innate aversion to immunological

More information

DMARD s in Clinical Practice

DMARD s in Clinical Practice DMARD s in Clinical Practice Professor Md. Mahabubul Islam Majumder Professor & Head, Department of Medicine Comilla Medical College, Comilla Bangladesh Disease-modifying antirheumatic drugs (DMARDs) A

More information

Opinion 23 July 2014

Opinion 23 July 2014 The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 23 July 2014 IMUREL 50 mg, film-coated tablet (B/100) (CIP: 34009 364 149 0 7) IMUREL 25 mg, film-coated tablet (B/50)

More information

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies Sarah Goglin MD Assistant Professor of Medicine Division of Rheumatology Disclosures None 1 [footer

More information

Personalized Medicine. Selecting the Right First-line Biologic Agent. Gene Expression Profiles Crohn s Disease. The Right Treatment

Personalized Medicine. Selecting the Right First-line Biologic Agent. Gene Expression Profiles Crohn s Disease. The Right Treatment Personalized Medicine Selecting the Right First-line Biologic Agent William Tremaine, M.D. Maxine and Jack Zarrow Professor Mayo Clinic Rochester, MN, USA The Right Treatment Pretreatment Genomic Analysis

More information

Supplementary table 1 online. Epidemiologic studies of non-occupational, non-infectious agents and systemic rheumatic diseases

Supplementary table 1 online. Epidemiologic studies of non-occupational, non-infectious agents and systemic rheumatic diseases Supplementary table 1 online. Epidemiologic studies of non-occupational, non-infectious agents and systemic rheumatic diseases Exposure Rheumatic Disease Comments (reference) Hormones SLE Prior hysterectomy

More information

Immunology 2011 Lecture 20 Autoimmunity 18 October

Immunology 2011 Lecture 20 Autoimmunity 18 October Immunology 2011 Lecture 20 Autoimmunity 18 October APC Antigen processing (dendritic cells, MΦ et al.) Antigen "presentation" Ag/Ab complexes Antigenspecific triggering B T ANTIGEN Proliferation Differentiation

More information

1 Eileen Ginsburg, DNP, FNP-BC, ARNP 10/10/2018

1 Eileen Ginsburg, DNP, FNP-BC, ARNP 10/10/2018 Rheumatology labs: Which to order and what do I do with the results? 1 Eileen Ginsburg, DNP, FNP-BC, ARNP 2 OBJECTIVES: By the end of the lecture you will 1. be able to decide which labs you want to order

More information

Committee Approval Date: May 9, 2014 Next Review Date: May 2015

Committee Approval Date: May 9, 2014 Next Review Date: May 2015 Medication Policy Manual Policy No: dru248 Topic: Benlysta, belimumab Date of Origin: May 13, 2011 Committee Approval Date: May 9, 2014 Next Review Date: May 2015 Effective Date: June 1, 2014 IMPORTANT

More information

Please fill in all the blanks or check the appropriate boxes, the starred fields (*) are optional:

Please fill in all the blanks or check the appropriate boxes, the starred fields (*) are optional: Alopecia Areata Registry: Short Form Questionnaire: Date of Revision: June 2010 Page 1 of 5 This questionnaire is only for people who live in the U.S.A and who have personal or family documentation of

More information

Raised serum IL-8 levels are associated with excessive fatigue in female carriers of X-linked Chronic Granulomatous Disease in the United Kingdom

Raised serum IL-8 levels are associated with excessive fatigue in female carriers of X-linked Chronic Granulomatous Disease in the United Kingdom Raised serum IL-8 levels are associated with excessive fatigue in female carriers of X-linked Chronic Granulomatous Disease in the United Kingdom Battersby A 1, Martin AJ 1, Tarn J 1, Ng WF 1, Cale C 2,

More information

Diagnostic and prognostic serological analyses in RA

Diagnostic and prognostic serological analyses in RA 9/9/ Diagnostic and prognostic serological analyses in RA Johan Rönnelid Clinical Immunology and Transfusion medicine Akademiska sjukhuset, Uppsala Department of Immunology, Genetics and Pathology Uppsala

More information

IdentRA test panel with eta. A clinically proven biomarker for earlier, accurate RA diagnosis and now, prognosis and monitoring

IdentRA test panel with eta. A clinically proven biomarker for earlier, accurate RA diagnosis and now, prognosis and monitoring IdentRA test panel with 14-3-3eta A clinically proven biomarker for earlier, accurate RA diagnosis and now, prognosis and monitoring Did you know there are more than 100 forms of arthritis? Every type

More information

Pathogenesis of lupus apoptosis clearance and regulation of self tolerance. Durga Prasanna Misra

Pathogenesis of lupus apoptosis clearance and regulation of self tolerance. Durga Prasanna Misra Pathogenesis of lupus apoptosis clearance and regulation of self tolerance Durga Prasanna Misra Format Apoptosis Apoptosis in SLE Decreased apoptosis of autoreactive cells Increased apoptosis Defective

More information

DocSpot what patients want to know

DocSpot what patients want to know DocSpot what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012 Copyright 2011 Raynaud's & Scleroderma Association. Charity Reg. No. 326306 DocSpot Live!

More information

Central tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response

Central tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. Mechanisms of Immune Tolerance ACTIVATION (immunity) SUPPRESSION (tolerance)

More information

Mechanisms of Immune Tolerance

Mechanisms of Immune Tolerance Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. ACTIVATION (immunity) SUPPRESSION (tolerance) Autoimmunity Immunodeficiency

More information

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of

More information

Interpreting Rheumatologic Lab Tests

Interpreting Rheumatologic Lab Tests The black hole of medical knowledge: An internist s view of rheumatologic lab tests Interpreting Rheumatologic Lab Tests Jonathan Graf, M.D. Associate Professor of Clinical Medicine University of California,

More information